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Immune reactivity to colorectal cancer has been suggested by an association between a pronounced peritumoral lymphocytic infiltrate and an improved prognosis (Jass 1986; Halvorsen and Seim, 1989; Di Giorgio et al, 1992) . However, the immune defence, if it was ever raised, appears to have deteriorated at least locally by the time tumours develop into clinically detectable lesions. This is in good agreement with the generally found suppression of various immune activities of tumour-infiltrating mononuclear cells (MNCs) (Nind et al, 1973; Klein et al, 1980; Bland et al, 1981; Hutchinson et al, 1981; Vose et al, 1981 Vose et al, , 1982 Vose and Moore, 1985; Miescher et al, 1986) . Such immunosuppression may be mediated by tumour-derived factors or subsets of MNC.
Some cytotoxic activity against malignant cells might, however, still be present in primary tumours as the degree of mononuclear cell infiltration has been found to correlate with a favourable prognosis in colorectal cancer (Svennevig et al 1984) and some other tumours (Haskil, 1982; Hutchinson et al, 1983; Lauder and Aheme, 1972; Shimokawara et al, 1982; Underwood, 1974; Werkmeister et al, 1979) . This may indicate that the local immunosuppression is reversible (Klein et al, 1980; Hutchinson et al, 1981; Vose and Moore, 1985; Rosenberg et al, 1986 ).
An increased number of lymphocytes was found in colon cancers compared with normal colons (Svennevig et al, 1982 ; Allen and Hogg, 1985) . These cells were mainly located to the stroma and not close to tumour cells (Svennevig et al, 1982; Allen and Hogg, 1985; Koch et al, 1985; Umpleby et al, 1985) . Eighty per cent of the lymphocytes expressed T cell characteristics, 17% B cell characteristics and 6% were null cells (Ebert et al, 1989) . The ratio between helper/inducer cells (CD4+) and cytotoxic/suppressor cells (CD8+ in colorectal cancers has varied considerably in different studies (Csiba et al, 1984; Lennard et al, 1984; Allen and Hogg, 1985; Koch et al, 1985; Umpleby et al, 1985; Ebert et al, 1989) .
Natural killer cells (NK cells) were either not found or were present in low numbers (Kornstein et al, 1983; Watanabe et al, 1983; Csiba et al, 1984; Koch et al, 1985; Ebert et al, 1989) . This is compatible with a depressed NK activity of tumour-infiltrating lymphocytes prepared from colon carcinoma compared with the activity found in autologous blood T cells from these patients (Bland et al, 1981; Vose et al, 1981) . The number of macrophages in tumours has varied from sparse (Komstein et al, 1983; Csiba et al, 1984; Ebert et al, 1989) to frequent (Watanabe et al, 1983; Allen and Hogg, 1985) .
Results from immunohistological studies are thus conflicting, and information on immunosuppressor and cytotoxic activities of tumour-infiltrating MNCs in colorectal cancer is almost lacking.
The aim of the present investigation was to use monoclonal antibodies to identify subsets of tumour-infiltrating mononuclear cells and study their pattern of distribution in relation to regressive tumour areas and Dukes' class.
MATERIAL AND METHODS

Patients
This report includes 22 primary colon and four rectal carcinomas from ten males and 16 females. Median age was 71 years (range 57-84). The number of tumours according to Dukes' classification was: A 3, B 13, C 5 and D 5. The majority of these tumours were moderately well differentiated. All Dukes' A, 2/13 Dukes' B and no Dukes' C tumours were well differentiated and one poorly differentiated tumour was found in each of Dukes' classes B, C and D.
Tumour preparation Surgical specimens were obtained from freshly resected colorectal carcinomas. The tumour tissue was immediately brought to the laboratory, cut into I x 1 cm pieces, embedded in OCT compound (Histo-Lab, Goteborg, Sweden), snap frozen in liquid nitrogen and stored at -70°C until further processed. Seven out of 26 biopsies used for immunohistochemical analyses of subsets of tumourinfiltrating inflammatory cells in this study were obtained at the advancing border of the tumour.
Monoclonal antibodies CD4 (Leu-3a, Beckton-Dickinson)
The antigen is present on helper/inducer T subset lymphocytes and in low density on monocytes and in the cytoplasm of monocytes and macrophages. Dilution of the antibody was 1:25.
CD8 (Leu-2a, Beckton-Dickinson)
The antigen is present on cytotoxic/suppressor lymphocytes. The antigen is also expressed on some Leu-11 + cytotoxic NK cells, on a subpopulation of Leu-7+ cells (which do not have cytotoxic and NK activity), on some Leu-8+ cells (which participate in suppression of B cell function) and on Leu-15+ cells, which are associated with suppressor function. Dilution of the antibody was 1:50. CD45R (2H4, Coulter, Stockholm, Sweden) The antigen is expressed on CD4+ and CD8+ T lymphocytes. It is present on some B and null cells. CD4-positive cells, which express this antigen, belong to the suppressor/inducer subset. Dilution of the antibody was 1:100. CD llc The antigen is present on monocytes and in low density on granulocytes and large granular lymphocytes in peripheral blood. It is also expressed on macrophages in normal lymphoid tissue and on Kupffer cells in liver and alveolar macrophages in lung tissue. Dilution of the antibody was 1:5.
CD25 (IL-2 receptor, Beckton-Dickinson)
The antigen, Tac-antigen or human receptor for interleukin-2 is present on activated T cells, B cells, NK cells and some macrophages. Dilution of the antibody was 1:25.
CD16 The antigen is present on human NK cells and neutrophils. It is associated with the Fc receptor for IgG. The antibody was undiluted.
CD11a (Immunotech, Stockholm, Sweden) The antigen, alpha-chain of the LFA-1 molecule, is present on granulocytes and macrophages. Dilution of the antibody was 1:100.
MHC I (HLA-ABC, Dakopatts)
The antibody is directed against a monomorphic epitope on the 45-kDa polypeptide products of the HLA-A, -B and -C loci. Dilution of the antibody was 1: 100.
MHC 11 (HLA-DR, Beckton-Dickinson)
The antigen is expressed on B lymphocytes, monocytes/ macrophages, activated T cells and some tumour cells. It is coexpressed with anti-Leu-6 on Langerhans cells of the epidermis. Dilution of the antibody was 1:50.
Immunological staining
The biopsies were cut into 6-gm sections and placed on multispot slides (Novakemi, Stockholm, Sweden) coated with a 0.5% gelatine solution. The sections were airdried for 3-18 h before staining and fixed for 10 min in acetone at 20°C. After drying, the sections were incubated with monoclonal antibodies (see above) for 30 min. Mouse IgG (Sigma, Stockholm, Sweden) was used as a negative control. After washing in phosphate-buffered saline (PBS) twice for 5 min, the sections were incubated with rabbit anti-mouse immunoglobulins (Dakopatts), washed and incubated with PAP mouse (Dakopatts). All dilutions were made in 0.5% PBS-HSA. All incubation times were 30 min. After washing, the slides were treated with 0.05% DAB (Sigma, Stockholm, Sweden) in 0.001I% hydrogen peroxide. Endogenous peroxidase activity was not blocked before the staining procedure. Human tonsils were used as a positive control. The slides were counterstained in Mayer's haematoxylin and mounted in Aquamount (Gurr, Malmo, Sweden).
Evaluation of peritumoral lymphocytic infiltrate
Routine, haemtoxylin and eosin-stained histopathological specimens were used to determine the infiltration of lymphocytes at the advancing border of the tumours. The degree of the infiltrate was scored as sparse or moderate/intense.
Evaluation of mononuclear cells
The distribution of infiltrating cells was often heterogeneous, and counting of cells per microscopic field was not performed. Instead, the overall occurrence of each subset of these cells in the intratumoral stroma and intermingled between tumour cells was scored as: -(absent), + (sparse, low numbers), ++ (moderate) and +++ (intense), independently by two investigators having no information about the patients or the result of routine histological examination. Inflammatory cells of necrotic areas were not registered in this study. There was a more than 90% agreement in the analyses between the two investigators.
CD4+ mononuclear cells, lymphocytes or macrophages were identified by their morphological appearance. Cells scored as lymphocytes had small nuclei and sparse cytoplasm with distinct cell membrane. In contrast, the macrophages displayed large nuclei and abundant generally faintly staining cytoplasm and they were irregularly invading between surrounding structures. Immunosuppressive activity within the CD8 subset was studied using MAb to antigen CD1lb. The type of cell, granulocytes, lymphocytes or macrophages, expressing this complement receptor was determined by their morphological appearance.
Statistical methods
The difference in distribution of inflammatory cells between Dukes' stages was analysed using the Fisher's exact test.
RESULTS
Peritumoral lymphocytic infiltrate
In routine histopathological examination, 12 patients had a sparse lymphocyte infiltration at the advancing border of the tumour and 14 had a moderate to intense infiltrate. All Dukes' A tumours showed a significant infiltration but seven out of 13 Dukes' B and five out of ten Dukes' C and D tumours had only a sparse lymphocyte infiltration. Twelve out of 14 tumours with a moderate to intense lymphocyte infiltration at the advancing border also had a moderate to intense infiltration of CD4+ cells when subsets of inflammatory cells in the intratumoral stroma were analysed. In contrast, in tumours with only a sparse infiltration at the border, six out of 12 tumours had a moderate to intense infiltration of CD4+ cells.
Subsets of tumour-infiltrating mononuclear cells (MNCs)
Seven out of 26 biopsies used for immunohistochemical analyses of subsets of tumour-infiltrating inflammatory cells in this study were obtained at the advancing border of the tumour. Five of these showed only a sparse, and two a moderate, inflammatory reaction at the border. In this study, only inflammatory cells in the intratumoral stroma or close to tumour cells were analysed. Thus, the inflammatory response at the advancing edge of the tumours was not included in the present analyses of subsets of tumour-infiltrating inflammatory cells and do not influence the results of this study.
The number and distribution of various subsets of MNCs in the intratumoral stroma and between tumour cells showed considerable individual variation. In all tumours except five, lymphocytes or monocytes were present in fairly large numbers, particularly in the stroma.
Stromal infiltration of the CD4+ mononuclear cells predominated over the CD8+ subset (Table 1) . Either CD4+ or CD8+ cells ( Figure lA) were present close to tumour cells in fairly high numbers in four tumours, in two of which both subsets were present simultaneously. A sparse infiltration of CD4+ and CD8+ cells between tumour cells was present in 16 and four tumours respectively. Focally large numbers of CD4+ cells were found in four of these tumours. CD4+ mononuclear cells were either lymphocytes or macrophages (Figure iB) . Out of 26 tumours, lymphocytes were in the majority in 12 and macrophages in six.
An attempt was made to study the suppressor activity of CD4+ and CD8+ lymphocytes further. Few tumours, however, showed moderate to intense infiltration of CD45R+ and CDllb+ cells (Table 1) and with no correlation to Dukes' class. Double staining, to identify CD4+CD45R+ helper-suppressor cells and CD8+CD 1 b+ suppressor lymphocytes, was therefore not done.
Moderate to intense stromal infiltration of CD 11 c+ macrophages ( Figure IC ) was found in all tumours except eight. Significant infiltration close to tumour cells was found in three and focal infiltration in another six tumours. The occurrence of CD 11 c+ cells was generally similar to that of CD4+ cells.
Tumour-infiltrating lymphocytes expressing the interleukin-2 (IL-2) receptor (CD 25) or the NK cell marker (CD 16) 
Anti-tumour activity of infiltrating MNCs
Focal areas with regressive changes of the tumour were frequently found in different parts of the tumour (Figure 2A , B and C). These areas were characterized by a deranged histological architecture, degenerating tumour cells and invasion of inflammatory cells: in 11 tumours by CD4+ cells (Figure 2A ), in 15 by CDllc+ cells ( Figure 2B ) and in two by CD8+ cells. CD1 b+ cells when present focally were mainly localized to these destruction areas. The appearance of these areas of tissue destruction suggests a causal relation to the cytotoxic activity of infiltrating cells.
Pattern of infiltrating MNCs and tumour stage according to Dukes' classification
In Dukes' A tumours, the stroma was infiltrated by CD4+ cells, the vast majority of which were lymphocytes. Cells expressing the antigen of CD45R or CD1lb, markers for immunosuppressive activity, in the CD4+ and CD8+ subsets, respectively, were absent or rare. The infiltration of monocytes/macrophages was sparse to moderate.
In Duke's B tumours, the stromal infiltration of CD4+ cells was of the same magnitude as in Dukes' A (Table 2 ). However, in Dukes' B tumours, many of these cells had the appearance of macrophages, but at least half of them were classified as lymphocytes in all tumours and lymphocytes were in the majority in 7/13 tumours. CD 1 Ic+ macrophages were frequently found in all tumours in this stage.
In Dukes' C and D tumours (Table 2) , 4/10 tumours showed a very poor inflammatory reaction. CD4+ cells were predominantly macrophages in 6/10 of these patients compared with 0/16 in Dukes' A and B (P=0.002). A moderate to intense infiltration of CD 1 c+ monocytes/macrophages was found in only a few patients. In contrast, Dukes' A and B tumours showed large numbers of these cells (P=0.05). 
DISCUSSION
The presence of CD4+ and CD8+ tumour-infiltrating lymphocytes in colorectal cancer has varied in different studies (Csiba et al, 1984; Lennard et al, 1984; Allen and Hogg, 1985; Koch et al, 1985; Umpleby et al, 1985; Ebert et al, 1989) . The conflicting results might to some extent be explained by the complex situation in these tumours, in which cytotoxic and immunosuppressor activities are present simultaneously (for further discussion see below). The predominance of CD4+ cells as found by us and others can be caused either by a preferential recruitment of these cells or by impaired proliferative response and reduced clonogenic potential, especially of tumour-infiltrating CD8+ cells (Miescher et al, 1988) .
In agreement with other reports, we found that tumour-infiltrating lymphocytes only occasionally display NK markers (Kornstein et al, 1983; Watanabe et al, 1983; Csiba et al, 1984; Ebert et al, 1989) . This is also compatible with previous data showing a depressed NK activity of tumour-infiltrating lymphocytes prepared from colon carcinoma (Bland et al, 1981; Vose et al, 1981) .
In this study, an intense infiltration of CD) lc+ macrophages was observed in the majority of the tumours. This was also found by Allen and Hogg 1985) , but is contradictory to other studies (Kornstein et al, 1983; Ebert et al, 1989) . Low numbers of macrophages in some reports on isolated mononuclear cells may be explained by a loss of surface markers or of macrophages themselves during the preparation procedures. CDllc+ macrophages were more frequently found in Dukes' B than in Dukes' C and D tumours and were also present in areas of cytodestruction, indicating a possible cytotoxic activity of these cells. CD4+ macrophages in colorectal cancer were described by Wood et al (1983) and Umpleby et al (1985) . In the present study, this type of macrophages as found in Dukes' B and predominated over CD4+ lymphocytes in Dukes' C and D tumours. Lymphocytes expressing the IL-2 receptor have been reported to increase in colon cancers compared with normal colon tissue and more in Dukes' C than B tumours (Allen and Hogg, 1985) . The interleukin-2 receptor-positive cells were found in significantly higher proportions in left-sided than in right-sided tumours, and in small tumours rather than in large ones (Ebert et al, 1989) . Surprisingly, IL-2 receptor-positive cells were found only rarely in the tumours analysed in this study.
As shown in this study and by others (Svennevig et al, 1982; Svennevig et al, 1984; Allen and Hogg, 1985; Koch et al, 1985; Umpleby et al, 1985) , the infiltration of mononuclear cells, as found in almost all tumours, was generally restricted to the stromal areas with fairly few cells infiltrating between tumour cells. This indicates chemotactic activity causing inflammatory cells to leave the blood vessels, but the migration of inflammatory cells close to tumour cells is inhibited. A gradient of immunosuppressive factors derived from tumour cells (Remacle-Bonnet et al, 1976; Whitehead and Kim, 1980; Ebert, 1986; Ebert et al, 1987) or macrophages or a high concentration of tumour-associated antigens shed into the tissue fluid might down-regulate the migration and cytotoxic activity of tumour-infiltrating lymphocytes (Baldwin et al, 1973; Nairn, 1976; Hutchinson et al, 1983) . As previously reported by Svennevig et al (1982) , the inflammatory cell infiltration was low in compact tumour tissue and areas of extensive necrosis in which the antigen concentration can be anticipated to be particularly high.
Cytotoxic activity against tumour cells in vivo has been reported (Kornstein et al, 1983) and was also demonstrated in the present study. In some tumours, focal areas of intense infiltration of mononuclear cells in close contact with tumour cells were found.
The patchy distribution of these areas is compatible with a regional variation in the immunogenicity of the tumours or variation in the concentration of chemotactic or blocking factors. Degeneration of tumours cells was often noticed and the histological architecture of the tumour tissue was often distorted in these areas. In contrast, other investigators (Svennevig et al, 1982; Allen and Hogg, 1985) did not find any sign of cytotoxic activity against tumour cells. The pattern of unorganized growth of poorly differentiated tumours might emerge partly as a result of immunological destruction of parts of the tumours leaving disorganized clusters of tumour cells, which are no longer susceptible to destruction by the immune system. These areas of destruction were generally heavily infiltrated by macrophages or CD4+ lymphocytes, which might be cytotoxic (Moretta et al, 1981) .
In several studies, no correlation was found between MNC infiltration (Ebert et al, 1989 ) and the degree of differentiation of the colorectal carcinomas (Csiba et al, 1984) or class according to Dukes (Hutchinson et al, 1983; Koch et al, 1985) . Svennevig et al (1984) have suggested that Dukes' stages could be further subclassified based on infiltrating lymphocyte subpopulations. The frequency of CD4+ macrophages was found to be increased in more advanced tumours in our study, which is in agreement with an increased infiltration of monocytes, especially in Dukes' C tumours, compared with normal colon tissue (Allen and Hogg, 1985) .
It has been reported that some colorectal carcinomas do not express MHC I antigens (Csiba et al, 1984; Umpleby et al, 1985; Momburg et al, 1986; Durrant et al, 1987) , which is consistent with our results. In one study, the expression of MHC I was correlated to the degree of differentiation of the tumours (Momburg et al, 1986) . The expression of the MHC II antigens of colorectal carcinoma cells varied considerably in different studies (Daar et al, 1982; Daar and Fabre, 1983; Csiba et al 1984; Momburg et al, 1986; Durrant et al, 1987) . Poorly differentiated or aneuploid tumours expressed more of these antigens than well-differentiated or diploid tumours Tumour infiltration by mononuclear inflammatory cells 379 (Rognum et al, 1983; Durrant et al, 1987) . However, no correlation between the expression of MHC I or II and the clinicopathological stage was found by others (Momburg et al, 1986; Durrant et al, 1987) . In the present study, most of the tumours expressing MHC II were also heavily infiltrated by CD4+ cells, which is compatible with induction of MHC II expression by interferon-gamma produced by these cells. A pronounced peri-and intratumoral lymphocytic infiltrate has repeatedly been shown to be related to a better prognosis (Jass, 1986; Halvorsen and Seim, 1989; Di Giorgio et al, 1992) . Our results on MHC II expression and appearance of CD4+ lymphocytes are, thus, in good agreement with the association between strong expression of HLA-DR and good prognosis as reported by Andersen et al (1993) . In contrast to our results, Daar et al (1982) did not find any correlation between the MHC II expression and the degree of mononuclear cell infiltration.
The function of tumour-infiltrating mononuclear cells can be interpreted as follows. As the tumours have managed to progress to clinically detectable lesions, the immune control of these tumours, if it was ever raised, must have broken down, at least locally. On the other hand, there is still some cytotoxic activity against the tumour cells, since specifically cytotoxic cells can be isolated from tumours and areas of cytodestruction are observed. Based on present knowledge, a pattern of down-regulation of the immune reactivity in progressive cancer disease can be suggested. Cytotoxic cells, e.g. CD8+ lymphocytes and macrophages infiltrate between the tumour cells in the early phase of the immune reactivity, as was the case in early oral cancers (Hiratsuka et al, 1984a, b) . These cells then disappear gradually, which can explain the variation in frequency of CD8+ cells in different studies. The dominating cells in Dukes' A tumours, in the present study, were CD4+ lymphocytes, while macrophages were sparse. In more advanced disease, macrophages were more frequent. The dominant infiltrating CD4+ cells changed from lymphocytes to macrophages, which comprised less than half of the cells in Dukes' B, but the majority of CD4+ cells in Dukes' C and D. This might suggest an immunosuppressor function of these macrophages.
